Table 2.
Insulin type | Molecule description | Strength | Percentage availability | ||
---|---|---|---|---|---|
Private-sector | Public-sector | ||||
Retail pharmacies [N = 30] | Hospital pharmacies [N = 5] | Hospital pharmacies [N = 5] | |||
Human insulin | Soluble Insulin | 40 IU/mla | 83.3% (n = 25) | 80.0% (n = 4) | 80.0% (n = 4) |
100 IU/ml | 33.3% (n = 10) | 80.0% (n = 4) | 20.0% (n = 1) | ||
Isophane Insulin | 40 IU/mla | 51.5% (n = 17) | 100.0% (n = 5) | 40.0% (n = 2) | |
100 IU/ml | 16.7% (n = 5) | 20.0% (n = 1) | 0.0% | ||
Biphasic Isophane Insulin: 30% Soluble 70% Isophane Insulin | 40 IU/mla | 93.3% (n = 28) | 100.0% (n = 5) | 80.0% (n = 4) | |
100 IU/ml | 66.7% (n = 20) | 80.0% (n = 4) | 40.0% (n = 2) | ||
Biphasic Isophane Insulin: 50% Soluble 50% Isophane Insulin | 40 IU/ml | 20.0% (n = 6) | 40.0% (n = 2) | 20.0% (n = 1) | |
100 IU/ml | 3.3% (n = 1) | 0.0% | 0.0% | ||
Analogue insulin | Insulin Aspart | 100 IU/ml | 33.3% (n = 10) | 60.0% (n = 3) | 20.0% (n = 1) |
Biphasic insulin aspart: 30% insulin aspart & 70% protamine crystallized aspart | 100 IU/ml | 36.7% (n = 11) | 20.0% (n = 1) | 20.0% (n = 1) | |
Insulin glargine | 100 IU/ml | 66.7% (n = 20) | 60.0% (n = 3) | 60.0% (n = 3) | |
Insulin glulisine | 100 IU/ml | 0.0% | 0.0% | 0.0% | |
Insulin detemir | 100 IU/ml | 3.3% (n = 1) | 20.0% (n = 1) | 0.0% | |
Insulin lispro | 100 IU/ml | 6.7% (n = 2) | 20.0% (n = 1) | 0.0% | |
Insulin lispro biphasic: 25% insulin lispro 75% lispro protamine | 100 IU/ml | 13.3% (n = 4) | 0.0% | 0.0% | |
Insulin lispro biphasic: 50% insulin lispro 50% lispro protamine | 100 IU/ml | 20.0% (n = 6) | 60.0% (n = 3) | 20.0% (n = 1) | |
Animal Insulin | Porcine soluble insulin | 40 IU/ml | – | 20.0% (n = 1) | – |
Porcine soluble insulin | 100 IU/ml | – | – | – | |
Mean availability of human insulins listed in 2015 India’s essential medicines list | 76.1% | 93.3% | 66.7% |
aInsulins listed on 2015 India’s essential medicines list